Vetr lowered shares of Monsanto Co. (NYSE:MON) from a strong-buy rating to a buy rating in a research note issued to investors on Tuesday morning. The firm currently has $111.12 price objective on the stock.

Other analysts have also issued research reports about the stock. Deutsche Bank AG lifted their target price on shares of Monsanto from $118.00 to $128.00 and gave the company a buy rating in a research report on Thursday, September 15th. BMO Capital Markets set a $128.00 price target on shares of Monsanto and gave the stock a buy rating in a research note on Thursday, September 15th. Monness Crespi & Hardt raised shares of Monsanto from a neutral rating to a buy rating and raised their price target for the stock from $106.93 to $130.00 in a research note on Monday, August 8th. Jefferies Group reissued a buy rating on shares of Monsanto in a research note on Tuesday, September 6th. Finally, Piper Jaffray Cos. set a $128.00 price target on shares of Monsanto and gave the stock a buy rating in a research note on Thursday, September 15th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and fifteen have given a buy rating to the company’s stock. The stock has an average rating of Hold and an average price target of $114.06.

Shares of Monsanto (NYSE:MON) traded down 0.11% during trading on Tuesday, reaching $101.64. 231,124 shares of the company’s stock were exchanged. The stock has a market cap of $44.52 billion, a P/E ratio of 34.02 and a beta of 1.01. Monsanto has a 12-month low of $83.73 and a 12-month high of $114.26. The company has a 50 day moving average of $101.09 and a 200 day moving average of $103.88.

Monsanto (NYSE:MON) last announced its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The business had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. During the same quarter last year, the business earned ($0.19) earnings per share. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. Equities research analysts anticipate that Monsanto will post $4.73 EPS for the current year.

In other news, Director Charles S. Mcmillan bought 3,500 shares of Monsanto stock in a transaction on Monday, October 10th. The shares were bought at an average cost of $103.23 per share, for a total transaction of $361,305.00. Following the acquisition, the director now owns 64,009 shares in the company, valued at $6,607,649.07. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Kerry J. Preete sold 2,745 shares of the company’s stock in a transaction dated Thursday, November 17th. The shares were sold at an average price of $100.96, for a total transaction of $277,135.20. Following the completion of the transaction, the executive vice president now owns 50,056 shares in the company, valued at $5,053,653.76. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MON. FMR LLC raised its position in Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the period. York Capital Management Global Advisors LLC purchased a new position in Monsanto during the third quarter worth about $332,725,000. Flossbach Von Storch AG purchased a new position in Monsanto during the third quarter worth about $238,397,000. Third Point LLC purchased a new position in Monsanto during the second quarter worth about $206,820,000. Finally, Carmignac Gestion purchased a new position in Monsanto during the second quarter worth about $197,555,000. Institutional investors own 78.26% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Monsanto Co. (MON) Lowered to Buy at Vetr Inc.” was originally reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark and copyright legislation. The correct version of this news story can be read at https://www.thecerbatgem.com/2016/11/23/monsanto-co-mon-lowered-to-buy-at-vetr-inc.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.